Cargando…
Predicting Norovirus in England Using Existing and Emerging Syndromic Data: Infodemiology Study
BACKGROUND: Norovirus is associated with approximately 18% of the global burden of gastroenteritis and affects all age groups. There is currently no licensed vaccine or available antiviral treatment. However, well-designed early warning systems and forecasting can guide nonpharmaceutical approaches...
Autores principales: | Ondrikova, Nikola, Harris, John P, Douglas, Amy, Hughes, Helen E, Iturriza-Gomara, Miren, Vivancos, Roberto, Elliot, Alex J, Cunliffe, Nigel A, Clough, Helen E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203923/ https://www.ncbi.nlm.nih.gov/pubmed/37155231 http://dx.doi.org/10.2196/37540 |
Ejemplares similares
-
Differential impact of the COVID-19 pandemic on laboratory reporting of norovirus and Campylobacter in England: A modelling approach
por: Ondrikova, Nikola, et al.
Publicado: (2021) -
Understanding norovirus reporting patterns in England: a mixed model approach
por: Ondrikova, N., et al.
Publicado: (2021) -
Estimating Disability-Adjusted Life Years (DALYs) in Community Cases of Norovirus in England
por: Harris, John P., et al.
Publicado: (2019) -
Community-based surveillance of norovirus disease: a systematic review
por: Inns, Thomas, et al.
Publicado: (2017) -
Norovirus in healthcare settings
por: Iturriza-Gómara, Miren, et al.
Publicado: (2014)